Bio Pro Classes:

Thursday, 17 Dec 2015 - Wednesday, 13 Apr 2016
Category: Bio Pro Classes

Tuesday, 09 Feb 2016
Category: Bio Pro Classes

Wednesday, 10 Feb 2016
Category: Bio Pro Classes

Wednesday, 10 Feb 2016
Category: Bio Pro Classes

Tuesday, 16 Feb 2016 - Wednesday, 17 Feb 2016
Category: Bio Pro Classes

Tuesday, 23 Feb 2016 - Wednesday, 24 Feb 2016
Category: Bio Pro Classes

Thursday, 25 Feb 2016 - Friday, 26 Feb 2016
Category: Bio Pro Classes

Tuesday, 01 Mar 2016
Category: Bio Pro Classes

Wednesday, 02 Mar 2016
Category: Bio Pro Classes

Wednesday, 02 Mar 2016
Category: Bio Pro Classes

Event Registration Cart

Your cart is empty.


Oregon Bio Launches Search for Executive Director

Job description posted below

The Oregon Bioscience Association (Oregon Bio), Oregon's only trade association that advances the creation and advancement of biotechnology and the life sciences, has launched its Executive Director search.

Oregon Bio is the leading voice for Oregon's bioscience industry. Our mission is to cultivate a thriving bioscience ecosystem in Oregon. We achieve this mission through advocacy, member support, energizing business formation and expansion, targeted workforce training and networking. Our members include a broad range of organizations and entrepreneurs involved in research, commercialization and advanced manufacturing of life science technologies.

The successful candidate for this high-profile position will be well versed in the strategy and objectives needed to create ongoing economic opportunities for Oregon's 800-plus life science companies and service providers. These comprise device and pharmaceutical manufacturers, biotech firms, bio-agricultural and environmental firms, and channel vendors, as well as the state's universities, hospitals, and research institutions.

Oregon Bio’s board and community members serve on the search committee, which is tasked with identifying established, regional leaders with strengths in fiscal management and operations; regional economic development policy and advocacy; membership acquisition and maintenance; and program management. Inquiries and resumes can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it..

 Job Description


News Release


Download PDF


Download PDF


News Flash

  • Brown announces grant support for small businesses, potentially boosting biotech

    Gov. Kate Brown says she wants small businesses to thrive in Oregon.

    As such, she's allocated $400,000 toward that end. The Small Business Innovation Research Grant Support Program will provide individual grants of $125,000 to four Oregon companies participating in a companion federal grant program, which is potentially good news for for bioscience startups.

    Several federal agencies, including the National Institutes of Health, provide grants to small businesses for research and development under the Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program.

    But those programs leave gaps, and earlier-stage companies are often courted by other states as they consider where to scale. The idea is to leverage federal dollars and prevent the flight of promising companies. SBIR/STTR matching grants are a tool used by 16 other states.

    "This support encourages more small businesses to stay and grow in Oregon," Brown said in a statement announcing the program.

    The Oregon Innovation Council will review applications and recommend award recipients. While they could come from a variety of realms, those in the biosciences would be likely candidates.

    In 2015, the National Institutes of Health awarded $17.5 million in SBIR grants to 24 Oregon companies (see below for a listing). Any company with a phase 2 grant could apply for the state funding. Those companies are past the phase of proving the science and are at the point of producing at commercialization plan, said Jennifer Fox, executive director of the Oregon Translational Research & Development Institute and the OTRADI Bioscience Incubator.

    “At a crucial time, that (funding) could make a big difference,” Fox said. “If you’re talking about building out your own space after you leave the incubator, it could be huge. More importantly, it’s that (the state is) listening to the needs of these companies.”

    Dennis McNannay, executive director of the Oregon Bioscience Association, said the state support is something he’s been advocating for over the past three years.

    “It’s great to see that first step, to get on that path,” McNannay said. “Obviously, we would like to see it grow. We know the demand and the need for these funds will grow. As more research begins to percolate out, the need will only get larger.”


    Feb 2, 2016
    Elizabeth Hayes
    Staff Reporter
    Portland Business Journal

Bioscience News

  • This past weekend I took my entire family and a friend and her mom to the Monsanto open house event.  We were treated to a nice non-organic buffet of local style appetizers from maki sushi to tonkatsu.  We also got to learn about the Japanese Cultural Center’s collaboration with Monsanto and the National Park Service in preserving the former Japanese internment camp known as Honouliuli. My kids had a chance to learn about bugs and Read More >

  • American chestnut trees are iconic image of American agriculture. Unfortunately, a terrible fungus has nearly wiped out the once estimated four billion that grew from Maine to Georgia. A recent piece in The Conversation explores the history of American Chestnut and Chestnut blight and how one “genetic tweak” could help restore its population. The species was nearly wiped out by chestnut blight, a devastating disease caused by the exotic fungal pathogen Cryphonectria parasitica. This fungus was accidentally Read More >

  • Check out today’s Wall Street Journal Editorial, highlighting why you can’t make medical progress by punishing medical advances. The editorial highlight’s how political attacks on the innovation ecosystem undermine the ability to bring important advances to patients. It notes that new initiatives, such as the Administration’s cancer “moonshot,” will be less likely to find success if short-sighted politicians create “investment uncertainty” that will drive away private capital away from the biopharmaceutical sector.” Read more in Read More >

joomla social media module

Underwriting Sponsors

Sustaining Sponsors

Principal Sponsors

Home | Bio in Oregon | BioPro Training | Events | Sponsors | Member Resources | News | About Us

Oregon Bioscience Association Copyright © 2016. All Rights Reserved.